| Indicators | Browse All

Drugs Made In America Acquisition Corp. (DMAAR)

New York, United States | NasdaqGM
0.11 USD +0.01 (9.238%) ⇧ (July 13, 2026, 4 p.m. EDT)

Short-term:☆☆☆☆☆Long-term:☆☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 4:26 a.m. EDT

This security presents a catastrophic investment case driven by a complete lack of liquidity and insolvency. The stock is trading at its 52-week low of $0.105 with negligible volume, indicating zero market interest. Fundamentally, the company is in severe distress with a negative book value of -$0.22, a current ratio of 0.03, and massive negative operating cash flow of nearly $3.8 million against $100k in debt. The business is an SPAC that has failed to complete a merger, evidenced by the appointment of a new CEO and the signing of a Letter of Intent rather than a finalized deal. With no price history to analyze trends, no dividends to provide income, and a balance sheet that suggests imminent liquidation, there is no rational basis for a long-term or short-term investment thesis.

None

Info Dump

Attribute Value
Address1 420 Lexington Avenue
Address2 Suite 1402
Ask 0.12
Ask Size 89
Bid 0.0904
Bid Size 1
Book Value -0.219
City New York
Country United States
Crypto Tradeable 0
Currency USD
Current Price 0.1147
Current Ratio 0.03
Custom Price Alert Confidence HIGH
Day High 0.1147
Day Low 0.0921
Display Name Drugs Made In America
Earnings Growth 0.188
Earnings Quarterly Growth 0.571
Earnings Timestamp End 1,747,771,200
Earnings Timestamp Start 1,747,771,200
Ebitda Margins 0.0
Esg Populated 0
Exchange NGM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Two Week High 0.1147
Fifty Two Week High Change 0.0
Fifty Two Week High Change Percent 0.0
Fifty Two Week Low 0.0921
Fifty Two Week Low Change 0.022599995
Fifty Two Week Low Change Percent 0.2453854
Fifty Two Week Range 0.0921 - 0.1147
Financial Currency USD
Float Shares 27,895,541
Full Exchange Name NasdaqGM
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Has Pre Post Market Data 1
Industry
Industry Key
Ipo Expected Date 2,025-02-25
Is Earnings Date Estimate 0
Language en-US
Long Business Summary Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
Long Name Drugs Made In America Acquisition Corp.
Market us_market
Market State PRE
Max Age 86,400
Message Board Id finmb_1889535116
Net Income To Common 6,656,559
Open 0.0921
Operating Cashflow -379,193
Operating Margins 0.0
Phone 646 726 7074
Previous Close 0.105
Price Hint 4
Price To Book -0.5237443
Profit Margins 0.0
Quick Ratio 0.03
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.0097
Regular Market Change Percent 9.238095
Regular Market Day High 0.1147
Regular Market Day Low 0.0921
Regular Market Day Range 0.0921 - 0.1147
Regular Market Open 0.0921
Regular Market Previous Close 0.105
Regular Market Price 0.1147
Regular Market Time 1,783,972,800
Regular Market Volume 939
Sand P52 Week Change 0.20847368
Sector
Sector Key
Shares Outstanding 20,400,000
Short Name Drugs Made In America Acquisiti
Source Interval 15
State NY
Symbol DMAAR
Total Cash 14,887
Total Cash Per Share 0.0
Total Debt 100,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Peg Ratio None
Triggerable 1
Type Disp Equity
Volume 939
Zip 10,170